ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
130.48
-1.16 (-0.88%)
Jun 2, 2026, 4:00 PM EDT - Market closed
ICU Medical Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, ICU Medical stock has a consensus rating of "Buy" and an average price target of $172.86. The average 1-year stock price forecast is 32.48% higher than the current stock price, while the lowest is $160 (+22.62%) and the highest is $200 (+53.28%).
Price Target: $172.86 (+32.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ICU Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 2 | 3 | 3 | 3 | 4 |
| Hold | 1 | 2 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Upgrades $165 | Buy | Upgrades | $165 | +26.46% | May 27, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $163 | Buy | Maintains | $163 | +24.92% | May 8, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $164 | Buy | Reiterates | $164 | +25.69% | May 8, 2026 |
Financial Forecast
Revenue This Year
2.17B
from 2.23B
Decreased by -2.53%
Revenue Next Year
2.27B
from 2.17B
Increased by 4.60%
EPS This Year
2.76
from 0.03
Increased by 9,196.36%
EPS Next Year
3.82
from 2.76
Increased by 38.20%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.2B | ||
| Avg | 2.2B | ||
| Low | 2.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.0% | ||
| Avg | -2.5% | ||
| Low | -2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.98 | ||
| Avg | 2.76 | ||
| Low | 1.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13,297.5% | ||
| Avg | 9,196.4% | ||
| Low | 4,377.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.